Heart, Lung, Blood and Sleep Disorders
Reminder!
The tier level is assigned to the guideline, NOT to the specific search terms. For example, a Tier 1 guideline has at least one recommendation that meets criteria for Tier 1, but also could include tier 2 or 3 recommendations.
DO read the guidelines to find out about specific search terms.
DON’T rely on the overall tier classification of the guideline for the specified search terms.
See More FAQ
Publication | Tier |
---|---|
Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Clinical Practice Guideline Update.
Giordano Sharon H et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018 Jun JCO2018792697 |
|
Genetic Evaluation of Cardiomyopathy - a Heart Failure Society of America Practice Guideline.
Hershberger Ray E et al. Journal of cardiac failure 2018 Mar |
|
Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).
Hershberger Ray E et al. Genetics in medicine : official journal of the American College of Medical Genetics 2018 Jun |
|
Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document.
Biegstraaten Marieke et al. Orphanet J Rare Dis 2015 10(1) 36 |